Alex Maas

Alex Maas is a Researcher at Erasmus University Medical Center within the Medical Faculty's Department of Hematology. His work focuses on molecular mechanisms in hematology, immunology, and genetics.

Research interests span Genetics, Molecular Biology, and Immunology, with specific expertise in

• Genome-Wide Association Studies
• Erythropoiesis regulation
• T cell exhaustion mechanisms
• Enhancer region functionality
• RNA-binding protein roles in hematopoiesis

Recent publications demonstrate strong activity in translational hematology and immunology, particularly in developing novel mouse models for T cell research (2025) and investigating molecular mechanisms in erythropoiesis disorders (2025). His work bridges basic molecular research with clinical applications in thalassemia and cancer immunotherapy.

Scientific contributions include:

• Key role in developing TOX-nanoluciferase reporter mouse model (2025)
• Discovery of CAPRIN2's role in erythroid production (2025)
• GWAS-based enhancer research in β-thalassemia (2025)
• Mesothelin-targeting antibody development (2024)

Dr. Maas collaborates extensively with researchers including Grosveld, Philipsen, Katsikis, and Erkeland across hematology and immunology projects. His work shows strong translational focus with multiple preclinical models developed for therapeutic applications.